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Abstract
The purpose of this study was to investigate the effects of green tea ingestion on hepatocarcinogenesis before and after its initiation. Male Sprague-Dawley
rats were fed an AIN76A diet with or without green tea. Initiation was induced by a single dose (200 mg/kg) of diethylnitrosamine at week 4
and 0.02% (w/w) 2-acetylaminofluorene was supplied in the diets. The control group had free access to water for 13 weeks (CTR13). Tea infusion
was provided from the beginning of the experiment for 13 weeks (PRE13) or from the post-initiation stage until week 13 (POST13). Three other 
groups (CTR24, PRE24 and POST24) were added to examine the longer-term effects (24 weeks) with the same experimental design. The percentage
area of liver sections that were positive for hepatic placental glutathione S-transferase (GST-P), which was used as a marker of preneoplastic lesions,
was smaller in PRE13 (20.2 ± 5.0%, mean ± SD) and POST13 (26.0 ± 4.8%) than in CTR13 (33.2 ± 5.8%, p<0.05). Over the longer period, the
GST-P lesions were significantly smaller for both PRE24 and POST24 (21.6 ± 8.5% and 22.2 ± 4.0%, respectively) than for CTR24 (28.6 ±5 . 1 % ,
p<0.05), but there was no significant difference between PRE24 and POST24. The liver content of thiobarbituric acid reactive substances was significantly
lower in the tea groups than in the controls (p<0.05). However, no significant differences were observed among groups of GST activity. The results
show that tea consumption exhibits a stronger short-term initiation-inhibiting ability in liver carcinogenesis, but over a longer period, the preventive
effects of green tea ingestion do not differ in post- and pre-initiation. 
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Introduction7)
Recent studies have demonstrated the potent antioxidant 
activity of green tea polyphenolics, leading to suggestions that 
green tea drinking reduces the risk for cancer (Ke et al., 2002; 
McKay & Blumberg, 2002; Su & Arab, 2002). Green tea and 
its constituents have been extensively studied both in vitro and in 
animal models of carcinogenesis (Yang et al., 2002). Although 
these compounds have been shown to be efficacious in a number 
of models of carcinogenesis, the epidemiological data on cancer 
prevention remain inconclusive (Arab & Il’yasova, 2003; Huang 
& Xu, 2004; Yang et al., 2002). Numerous potential mechanisms 
have been proposed for the cancer-preventive activity of green 
tea based on the strong antioxidative activity of tea polyphenols 
(Ahmad et al., 2001; Dreosti, 1996; Feng et al., 2001). Many 
studies have focused on epigallocatechin gallate and theaflavins 
as chemopreventive agents that inhibit the growth and induce 
cell cycle arrest and apoptosis in various cancer cell lines (Takada 
et al. 2002; Yang et al., 1998; Yang et al., 2002). The relative 
importance of any of these mechanisms in vivo remains to be 
determined since most in vitro studies have employed concentrations 
of tea compounds that far exceed those found in animal plasma 
or tissue following reasonable tea consumption (Lambert & Yang 
2003). To overcome this shortcoming, we designed experiments 
involving green tea supplementation as the sole source of fluid 
at human-achievable doses.
Chemoprevention consists of the pharmacological use of one 
or more substances with the purpose of delaying, or even reverting, 
the carcinogenic process before the emergence of malignancy 
(Gescher et al., 2001). Despite the great advances in diagnosis 
and treatment, cancer mortality rates (especially of liver cancer) 
remain high (Guyton & Kensler, 1997; Korea National Statistical 
Office, 2008), mainly in developing countries (Barret, 2002). 
Although  in vitro and in vivo animal studies have provided 
evidence of the beneficial effects of green tea polyphenols at 
most stages of cancer development and have identified many 
possible sites of action in cancer prevention (Chen et al., 2000; 
Lin, 2002) the relevance of these studies is uncertain due to the 
experimental polyphenol concentrations being higher than those 
attainable via normal dietary intake of green tea (Henning et al., 
2005; Yang et al., 2001).
Therefore, the present study evaluated the chemopreventive 
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Table 1. Polyphenol contents of the green tea
1)
Tea polyphenols Dried tea leaves
(mg/g) SD Tea infusion
2)
(mg/100ml) SD
Epigallocatechin 11.5 2.1 12.4 1.2
Epicatechin 10.4 2.3 7.9 2.9
Epigallocatechin gallate 49.0  2.8 33.7 1.8
Epicatechin gallate 10.2  5.3 7.6 3.6
Total 81.1 3.5 61.5 5.6
1) Means  of  triplicates
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Fig. 1. Experimental design. ↑, 200mg DEN in 2.0㎖ saline/kg BW i.p. injection; 
, AIN 76A diet and deionized water;  , AIN 76A diet and green tea as a sole 
drinking solution;  , AIN 76A with 0.02% AAF in diet;  , AIN 76A with 0.02% 
AAF in diet and green tea as a sole drinking solution; † , sacrifice. CTR13, control 
group  for  13  wk;  POST13,  green  tea  ingestion  for  7  wk  from  the  post-initiation 
period;  PRE13,  green  tea  ingestion  fore  13  wk,  preinitiation;  PRE24,  green  tea 
ingestion  for  24  wk,  preinitiation;  POST24,  green  tea  ingestion  for  18  wk,  post- 
initiation  period;  CTR24,  control  group  for  24  wk.
activities of green tea ingestion both prior to the initiation stage 
(pre-initiation) and during the promotion stage (post-initiation) 
of hepatocarcinogenesis. We intended to clarify the effects of the 
duration and timing of green tea ingestion on hepatocarcinogenesis 
induced by diethylnitrosamine (DEN) and 2-acetylaminofluorene 
(2-AAF) in male rats. We conducted a study on the hematocar-
cinogenesis since liver cancer is still a leading cause of cancer 
mortality in Korea, which is the highest liver cancer mortality 
among OECD countries (Korea National Statistical Office, 2008). 
The percentage area of foci that were positive for placental 
glutathione S-transferase (GST-P) was measured as a marker of 
preneoplastic lesions, since the degree of induction of GST-P 
positive foci is directly correlated with the incidence of hepatocellular 
carcinomas in long-term in vivo systems (Tatematsu et al., 1988). 
Because DEN and 2-AAF are metabolized through phase I and 
phase II drug-metabolizing enzymes, we hypothesized that green 
tea modulates these enzymes, and thereby affects hepatocarcinogenesis. 
Therefore, we measured cytochrome P450 (CYP) content and 
glutathione S-transferase (GST) activities. We also measured the 
contents of thiobarbituric acid reactive substances (TBARS) in 
liver microsomes as an index of lipid peroxidation. Two sets 
of experiments were conducted with different durations to 
examine the extents to which green tea modulates the chemical 
carcinogenic effects before and after initiation.
Materials and Methods
Preparation and analysis of green tea 
Twenty-five grams of green tea (Sullok Green Tea, Pacific 
Corporation, Seoul, Korea) were added to 1 L of 80℃ boiled, 
distilled and deionized water and left to stand at room temperature 
(25℃) for 5 min. The brewed tea was filtered through several 
layers of cheese cloth. The contents of several phenolic compounds 
were analyzed by reverse-phase high performance liquid chroma-
tography (TOSOH with a UV detector at 280nm, Tokyo, Japan; 
C18 Shiseido Cap Cell Pack, 5μm particle size, 250×4.6mm, 
Shiseido, Tokyo, Japan). The mobile phase contained 250 mL 
of 25% 1, 2, 3, 4-tetrahydro-9-fluorenone and 750mL of 1% 
phosphoric acid. The column was maintained at room temperature 
(25℃), and the flow rate of the mobile phase was 0.8mL/min. 
Table 1 lists the polyphenols composition of brewed green tea 
used in the experiment.
Animals and diets
Study protocols were approved by the Institutional Animal 
Care and Use Committee of Seoul National University.
There were two experimental periods, of 13 and 24 weeks, 
each with pre-initiation and post-initiation and two control 
groups. Male Sprague-Dawley rats (80~90 g) were supplied by 
the Seoul National University Animal Care Facility. The rats 
were housed at two per suspended stainless steel cage with wire 
mesh bottoms that were kept in a humidity- and temperature- 
controlled room (55 ± 1% and 20 ± 1℃, respectively) with a 12-h 
light:dark cycle. The rats had free access of deionized water and 
a commercial diet (Rat chow, SamYang Animal Chow Co., 
Seoul, Korea) for one week before they were divided into six 
experimental groups, with six rats allocated to each group. The 
experimental design is shown in Fig. 1. Rats in two control 
groups of 13 weeks (CTR13) and 24 weeks (CTR24) consumed 
a diet formulated to meet recommended nutrient levels for rats 
(AIN76A) (AIN76A, American Institute of Nutrition, 1980), and 
distilled water. Rats in the tea groups consumed an AIN76A diet, 
with green tea being the sole source of fluid for the entire 13- 
or 24-week experimental period (PRE13, PRE24, POST13 and 
POST24). Rats were injected with DEN intraperitoneally as a 
single dose of 200 mg/kg body weight after 4 weeks of feeding. 
From 2 to 12 weeks after the DEN injection, the rats consumed 
a diet that included 0.02% (W/W) 2-AAF. We sacrificed rats 
at weeks 13 and 24. 
Placental glutathione S-transferase positive foci
Upon killing the animals by decapitation after 12 h of fasting, 
the livers were immediately excised and rinsed with saline 
solution. Blot-dried livers were weighed and cut into 2- to 
3-mm-thick sections with a blade. These liver slices were fixed 236 Green tea effects on rat hepatocarcinogenesis
Table 2. Effect of green tea infusion on the body weight, liver weight and 
liver/body weight ratio
Group (N) Body weight (g) SD Liver weight (g) SD Liver/body 
weight ratio SD
CTR13 (6) 432.8
ab 61.5 12.9 2.9 2.95
ab 0.29
PRE13 (5) 403.4
b 55.0 12.0 1.5 3.01
ab 0.37
POST13 (6) 421.5
ab 37.2 14.2 3.1 3.34
a 0.52
CTR24 (6) 501.8
a 46.9 12.8 1.5 2.56
b 0.25
PRE24 (5) 464.2
b 58.2 14.3 4.2 3.00
ab 0.65
POST24 (5) 500.8
ab 29.1 16.9 3.6 3.36
a 0.43
CTR13, control group for 13 wk; POST13, green tea ingestion for 7 wk from the 
post-initiation period; PRE13, green tea ingestion fore 13 wk, preinitiation; PRE24, 
green  tea  ingestion  for  24  wk,  preinitiation;  POST24,  green  tea  ingestion  for  18 
wk,  post-initiation  period;  CTR24,  control  group  for  24  wk.
Mean values within a column with unlike superscript letters are significantly different 















































Fig. 2. Effect of green tea ingestion on the area of placental glutathione 
S-transferase positive foci. Means  without  a  common  letter  differ  (p<0.05)  with 
ANOVA  and  Duncan’s multiple  post-hoc  test.
in ice-cold acetone for immunohistochemical examination of 
GST-P positive foci. The avidin-biotin-peroxidase-complex 
method was used to demonstrate GST-P positive liver foci. 
Immunohistochemical analysis was carried out with sequential 
treatments of rabbit anti-rat placental glutathione S-transferase 
(BMI Inc., Tokyo, Japan) as a primary antibody, swine anti-rabbit 
IgG antibody (BMI Inc.) as a secondary antibody and peroxidase- 
antiperoxidase complex (Vectastain Elite ABC kit, Vecta 
Laboratories, Burlingame, USA). Final visualization of GST-P 
positive foci was enzymatically activated by 3,3-diaminobezidine 
(Sigma Chemical Co., St. Louis, USA) and H2O2 as substrate. 
The total areas of GST-P positive foci with diameters larger 
0.2mm in the liver sections were measured using an image 
analyzer program (Bummi Universe, Ansan-si, Korea), and 
expressed as a percentage of the total area.
Biochemical assays
Microsomal and cytosolic fractions were prepared according 
to a modified version of the methods of Sohn et al. (1994). A 
portion of the liver was finely minced in three weight volumes 
of ice-cold 50 mM Tris-HCl buffer, pH 7.4, containing 1mM 
EDTA, and then homogenized. Homogenates were centrifuged 
at 12,000×g for 20min and, microsomes were obtained by 
centrifuging the resulting supernatant at 105,000×g for 1h. After 
collecting the cytosolic fraction, microsomes were resuspended 
in three weight volumes of 50 mM Tris-HCl buffer, pH 7.4, 
containing 1mM EDTA. Cytosol and microsomal suspensions 
were frozen by liquid nitrogen and stored at -70℃ until assayed.
Lipid peroxides of the hepatic microsomes were determined 
by measuring the formation of TBARS (Buege & Aust, 1978). 
Malondialdehyde as the product of lipid peroxidation was reacted 
with thiobarbituric acid, and the absorbance of the resulting 
chromophore was measured at 535nm. GST activity was assayed 
in the hepatic cytosolic fraction using the method of Habig et 
al. (1974). Total CYP content was determined according to the 
method of Omura and Sato (1964). Fresh liver microsomes were 
added to sodium dithionate, and the reduced hemoprotein was 
combined with carbon monoxide by bubbling CO gas through 
the solution. The characteristic absorbance at 450 and 490nm 
was measured by dual-beam spectroscopy. The protein amounts 
of hepatic microsomes and cytosolic fractions were determined 
by Lowry’s method (Lowry et al., 1951).
Statistical analysis
All statistical comparisons were performed using ANOVA with 
SAS program (version 9.1, SAS Inc., Cary, USA). A p-value 
of less than 0.05 was selected as the cutoff for statistical 
significance based on Duncan’s multiple post-hoc test.
Results
Green tea ingestion significantly reduced the final body weight 
when introduced from the beginning of the experiment (p<0.05 
for PRE13 vs. CTR13 and PRE24 vs. CTR24, Table 2). However, 
when tea was introduced from the post-initiation stage (POST13 
and POST 24), final body weights were not different from 
corresponding control groups. Although tea did not affect liver 
weights (Table 2), the relative liver weight was significantly 
increased with tea ingestion from post-initiation up to week 24 
(3.36 ± 0.43 g of POST24 vs 2.56 ± 0.25 g of CTR24, p<0.05).
Fig. 2 presents the area of GST-P positive foci, the preneoplastic 
lesions. Suppressive effects of green tea ingestion on the induction 
of GST-P positive foci were observed both at weeks 13 and 24 
(p<0.05) compared to the corresponding control groups. However, 
at week 13, green tea ingestion from prior to the introduction 
of initiator reduced lesion further than green tea ingestion started 
from post-intiation (p<0.05, PRE13 vs POST13) while no 
difference was observed between green tea ingestion from pre- 
and post-intiation at week 24. The areas of GST-P positive foci 
at week 13 were similar to those at week 24 (33.2 ± 5.8% of 
CTR13 vs. 28.6 ± 5.1% of CTR24).
TBARS content, GST activity and CYP content are given at 
Table 3. Liver microsomal lipid peroxidations determined by Hyung-Sook Kim et al. 237
Table 3. Effect of green tea infusion on thiobarbituric acid reactive substances
content, glutathione S-transferase activity and cytochrome P450 content at week















a 1.68 2.32 0.63 0.94 0.21
PRE13 (5) 3.85
b 0.23 2.51 0.53 0.93 0.22
POST13 (6) 3.80
b 1.75 2.69 0.66 0.94 0.14
CTR24 (6) 2.92
b 1.34 2.21 0.68 0.73 0.24
PRE24 (5) 0.60
c 0.39 3.02 0.60 0.85 0.24
POST24 (5) 0.69
c 0.26 3.00 0.49 0.60 0.20
TBARS, thiobarbituric acid reactive substances; GST, glutathione S-transferase; CYP, 
Cytochrome P450; CTR13, control group for 13 wk; POST13, green tea ingestion 
for 7 wk from the post-initiation period; PRE13, green tea ingestion  fore  13  wk, 
preinitiation; PRE24, green tea ingestion for 24 wk, preinitiation; POST24, green tea 
ingestion  for  18  wk,  post-initiation  period;  CTR24,  control  group  for  24  wk.
Mean values within a column with unlike superscript letters are significantly different 
(P<0.05)  with  ANOVA  and  Duncan’s  multiple  post-hoc  test.
TBARS of rats ingested tea were significantly lower than those 
of control groups (p<0.05). The average of TBARS content at 
week 13 was higher than at week 24 (p<0.05). No significant 
differences were observed among groups of GST activity and 
CYP content.
Discussion
In the present study, we observed anticarcinogenic effects of 
green tea with different duration and timing of ingestion on rat 
hepatochemical carcinogenesis induced by DEN and 2-AAF. We 
sacrificed rats at weeks 13 and 24 from the initiation of the 
experiment because we would like to examine if green tea 
modulated the metabolism in rat liver induced by chemical 
carcinogens at different periods of time and if it prolonged the 
effects after finishing administration of chemical carcinogens. As 
an index of preneoplastic lesion, we measured the area of GST-P 
positive foci which shows a good correlation with the incidence 
of hepatocellular carcinomas revealed in long term in vivo 
systems (Tatematsu et al., 1988). When we terminated the 
experiment at week 13, green tea ingestion from the post-initiation 
stage decreased the area of GST-P positive foci by about 22% 
while about 32% reduction was observed when tea was introduced 
from the beginning of the experiment. However, further reduction 
of green tea ingestion before the initiator was not observed when 
the experiment was continued until week 24. The results support 
the suppressive effect of green tea on hepatocarcinogenesis in 
rats with a human-achievable dose, which is a relatively low dose 
compared to in vitro or single dose in vivo studies. These results 
suggest that green tea reduced carcinogenesis during drugs 
(initiator or promoter) administration, but it might not affect on 
hepatocarcinogenesis after administering carcinogens because no 
further reduction of GST-P lesion up to week 24 compared to 
week 13 was observed. It seemed to be more effective to drink 
tea before the administration of carcinogens than during drug 
administration for a short-term period, but if tea ingestion is 
prolonged for a longer period, the same effect of tea ingestion 
was observed whether tea drinking was started from pre- or 
post-intiation. Yang et al. (2001) previously reported that 
polyphenols, which are effective when given during the 
post-initiation period by inhibiting tumor promotion and 
progression, are believed to be more useful in preventing cancer 
in humans than are polyphenols, which are effective only when 
given before and during the carcinogen treatment. Our study 
showed no difference in cancer preventive effects of tea between 
pre- and post-initiation ingestion if tea was ingested for an 
extended period up to 24 weeks. Regarding the results of 24-week 
experiment of no difference between PRE24 and POST24 in 
GST-P positive foci areas, tea may have inhibitory activity 
against hepatocarcinogenesis when administered before and 
during the initiation or promotion stages. The broad inhibitory 
activity of tea has been reported on lung cancer as well as skin 
cancer (Conney et al., 1997). Our results can add another support 
of broad inhibition activity of tea on hepatocarcinogenesis. The 
results of 13-week experiment, however, showed differences 
between PRE13 and POST13 in GST-P lesion. With a relatively 
low dose, duration of tea ingestion seems to be important. This 
result may explain the controversial results found from epidemiology 
studies. Some cross-sectional studies without information on the 
duration of tea drinking may result in biased effects of tea 
drinking. Even if we used a relatively low dose of tea, using 
tea as a sole source of drinking liquid seemed to be stressful 
to the growing rats in this experiment. Rats in PRE 13 and 24 
groups did not show full growth as the control groups and we 
lost one animal each from PRE13 and 24 groups in the middle 
of the experimental period. However rats in POST initiation 
groups grew as well as the control groups although one more 
animal in POST24 could not survive up to the termination of 
the experiment. For the fast growing young animals, initial 
growth retardations due to drinking tea instead of water could 
be somewhat stressful to fully recover their physiological functions.
We measured TBARS contents to determine the level of lipid 
peroxidation in liver microsome. TBARS contents were higher 
at week 13 than week 24 because TBARS induced by chemical 
carcinogens (Tian et al., 2001). Farombi et al. (2000) reported 
that TBARS contents of rat fed 0.02% 2-AAF in diet induced 
2.5 times higher than those of rats fed control diet. In the present 
study, the contents of TBARS in the control group at week 13 
(one week after 2-AAF administration) were 1.75 times higher 
than those at week 24 (ten weeks after 2-AAF administration, 
CTR13 vs CTR24). On the other hand, for the tea groups, 
TBARS contents at week 13 were about 5.5 times higher than 
those at week 24. At week 13, chemical carcinogen induced lipid 
peroxidation effects would be higher than at week 24 due to 
a shorter time period since 2-AAF administration. This may be 
confirmed by the previous study, which indicated TBARS 
induction was decreased as time passed by (Farombi et al., 2000; 
Tian  et al., 2001). TBARS contents of rats in the tea groups 238 Green tea effects on rat hepatocarcinogenesis
were lower than those of rats in the control groups. The reduction 
of TBARS by green tea was more significant with longer 
ingestion of tea. According to the investigation with breast cancer 
patients, plasma malondiadehyde level may decrease in advanced 
stages of cancer (Alagol et al., 1999). Therefore, the big 
difference of TBARS levels between week 13 and 24 in the tea 
groups may appear from the combination effects of the 
carcinogens, tea and the metabolism in late stage of cancer. 
GST activities of rats sacrificed at week 13 were not changed 
by green tea. It has been reported that lipid peroxidation reduced 
glutathione levels, and then GST activity decreased (Ozdemirler 
et al., 1999). However, we could not observe negative correlation 
between TBARS and GST activity. CYP contents of the green 
tea groups at both week 13 and 24 were not different from that 
of the corresponding control groups. CYP is a main component 
of phase I drug metabolism, which activates carcinogenesis. 
Previously, DNA damage can be reduced through decreasing 
Phase I drug metabolites, CYP3A, by grapefruit juice (Miyata 
et al., 2004) and we expected the same effects with green tea. 
However, such effect was not observed in our study. Green tea 
ingestion did not modify Phase I and II drug metabolism during 
hepatocarcinogenesis in the present study. The anticarcinogenic 
effects, therefore, may be mainly attributable to the antioxidants 
effects in green tea. 
In conclusion, this study proved that green tea has anticarcinogenic 
effects through reduction of preneoplastic lesions, GST-P positive 
foci. The effect was more significant when tea was ingested 
before the drug administration for a short term, but for a long 
term period, green tea ingestion was beneficial regardless of 
ingestion timing. 
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